{
    "2021-04-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Seeks Skyrizi Approval for Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Skyrizi",
                        "Approval",
                        "Psoriatic Arthritis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Is It Time To Buy AbbVie Stock â€” Or Will Pfizer's Bad News Continue To Hurt?",
                "features": {
                    "keywords": [
                        "Buy",
                        "AbbVie Stock",
                        "Pfizer",
                        "Bad News"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}